Bavarian Nordic A/S Sustainability Reports

Bavarian Nordic A/S is a fully integrated biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The company is a key provider of travel health vaccines and public health preparedness countermeasures against diseases such as mpox, smallpox, rabies, and chikungunya.

Sector: Manufacturing

Country: Denmark

Exchange: Nasdaq Copenhagen

ISIN: DK0015998017

28 reports from 2006 to 2025

• Bavarian Nordic A/S 2025 Corporate Governance Report
• Bavarian Nordic A/S 2025 Annual Report
• Bavarian Nordic A/S 2024 Annual Report
• Bavarian Nordic A/S 2023 Annual Report
• Bavarian Nordic A/S 2023 Sustainability Report